Source: Kansas State University
Date: July 10, 2008
Summary:
Kansas State University researchers are working on a method of delivering cancer drugs that promises to be more efficient and reduce the side effects. The researchers are using stem cells isolated from Wharton's jelly, the substance that cushions blood vessels in the umbilical cord. These types of stem cells can be harvested noninvasively and therefore are not controversial. Deryl Troyer, professor of anatomy and physiology at K-State's College of Veterinary Medicine, said the stem cells display a sort of homing ability in that they tend to travel to tumors and other pathological lesions. The researchers are using these stem cells as delivery systems by loading the cells with nanoparticles that contain anti-cancer drugs.
